Target Corp. has agreed to sell its pharmacy and clinic businesses to the drugstore chain CVS Health Corp. for about $1.9 billion in a deal that combines the resources of two retailers seeking to polish their health care reputations.
Axovant Sciences Ltd., a company without a finished product or a dime of sales, has an almost $3 billion valuation after its public-market debut. The IPO shows the staggering potential for any company that can develop a successful Alzheimer’s treatment.
Anthem Blue Cross and Blue Shield has added St. Vincent Health to the “narrow network” of health care providers it uses for Obamacare plans.
The National Labor Relations Board declined to dismiss charges that IU Health broke the law by firing one nurse and disciplining another who were involved in trying to form a union at Methodist Hospital.
Dr. Kent Brantly was awarded the Dr. Nathan Davis International Award in Medicine from the American Medical Association for his service in Liberia during last summer’s Ebola outbreak.
Progress in reducing smoking is undeniable, but money to accelerate the decline is falling even faster.
Millions of people will be able to see a doctor on their smartphones or laptops for everyday ailments once the nation's largest drugstore chain and two major insurers expand a budding push into virtual health care.
A medical software company is notifying patients of the health care providers it serves—including Franciscan St. Francis Health in Indianapolis—that their private information may have been exposed when its networks were hacked.
Eli Lilly stock rose 5.4 percent per share on Tuesday, its biggest daily increase since March 2009, after Elanco President Jeffrey Simmons was asked if Lilly might one day shed the unit in an initial public offering.
Indianapolis-based Eli Lilly and Co. plans to introduce its version of Sanofi’s Lantus insulin for diabetes in Europe in the third quarter, said Enrique Conterno, the president of Lilly Diabetes.
An experimental pill to treat low sexual desire in women moved closer to becoming the first such drug to be sold in the U.S. after regulatory advisers backed its approval.
While health insurers in states around the country have proposed large rate increases for the health plans they sell on the Obamacare exchanges, insurers in Indiana are asking for modest increases or even decreases. The bad news is that it appears the rest of the country is just catching up with Indiana’s already-high prices.
Thousands of Indiana children who raised and doted on chickens, turkeys and other poultry for 4-H projects are feeling the sting of a statewide ban on bird shows aimed at preventing the spread of a bird flu.
In the 1920s, Indianapolis was one of the most innovative cities in the nation. But after “the dark tragedy of the roaring twenties,” Indianapolis lost its edginess for decades and only recently has begun to regain it.
The drugmaker plans to sell 2.1 billion euros ($2.3 billion) of securities in three parts, according to a person familiar with the matter who asked not to be identified.
Goodwill Industries of Central Indiana Inc. is appealing a decision by the Richard L. Roudebush Veterans Affairs Medical Center that would put 63 janitors and their four managers out of work by Aug. 1.
Community Health Network said Thursday that it will spend $175 million to build a hospital on its East campus instead of renovating existing facilities. It also plans to build a $60 million cancer center on its North campus in the Castleton neighborhood.
In a bid to get into the white-hot market for drugs that use the body’s immune system, Eli Lilly and Co. will spend $60 million to form a research partnership with Germany-based BioNTech.
Verve Health, an Indianapolis-based company that provides wellness and health clinics to employers, is pitching a new option—integrative medicine. If plans are successful, it could add more than 100 workers in the next year.
Indiana Gov. Mike Pence signed a bill into law on Tuesday that gives civil immunity to volunteer health care providers.
